| 000 | 01554 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514212116.0 | ||
| 264 | 0 | _c20050519 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a1526-8209 | ||
| 024 | 7 |
_a10.3816/cbc.2004.n.040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarbeck, Nadia | |
| 245 | 0 | 0 |
_aUrokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer. _h[electronic resource] |
| 260 |
_bClinical breast cancer _cDec 2004 |
||
| 300 |
_a348-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xanalysis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xanalysis |
| 700 | 1 | _aKates, Roanld E | |
| 700 | 1 | _aSchmitt, Manfred | |
| 700 | 1 | _aGauger, Katja | |
| 700 | 1 | _aKiechle, Marion | |
| 700 | 1 | _aJanicke, Fritz | |
| 700 | 1 | _aThomassen, Christoph | |
| 700 | 1 | _aLook, Maxime P | |
| 700 | 1 | _aFoekens, John A | |
| 773 | 0 |
_tClinical breast cancer _gvol. 5 _gno. 5 _gp. 348-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3816/cbc.2004.n.040 _zAvailable from publisher's website |
| 999 |
_c15269718 _d15269718 |
||